北五味子在胸主动脉瘤发生发展中作用机制的网络药理学和分子对接技术分析

doi:10.13481/j.1671-587X.20220219

Abstract

Abstract: Objective

To investigate the effect of Schisandrae Chinensis Fructus（SCF）in the occurrence and development of thoracic aortic aneurysm（TAA）， and to clarify its possible mechanism. Methords：The informations from multiple databases of Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform（TCMSP），Uniprot， Swiss TargetPrediction，CTD，GeneCards， OpenTargets， and OMIM were integrated to obtain the potential targets for the treatment of TAA by SCF； the protein-protein interaction （PPI） network was constructed by String database and Cytoscape software， and the key targets of SCF acted on TAA were selected by topological analysis； Omicshare online analysis platform was used to conduct GO and KEGG enrichment analysis on the potential targets； the gene expression profile of rat smooth muscle cells stimulated by Schisandra chinese（turcz.） baill （SchB）， the main active ingredients of SCF was obtained from GEO database to verify the expression levels of core targets； Autodock software was used for molecular docking validation of key targets.

Results

A total of 46 potential targets of SCF protected against TAA were obtained； GO enrichment analysis mainly involved biological processes such as cell proliferation， catalytic activity， protein metabolic process and so on； KEGG enrichment analysis mainly involved three signal pathways， including vascular endothelial growth factor （VEGF）， receptor tyrosine-protein kinase （ErbB） and hypoxia-inducible factor 1（HIF-1）.The 10 core targets such as signal transducer and activator of transcription 3 （STAT3） and matrix metalloproteinase 9 （MMP9） were obtained by topological network analysis. The results of gene expression profile showed that compared with TGF-β1 group， the expression levels of core target genes STAT3 and MMP9 in TGF-β1-SchB group were significantly down regulated（P<0.05）.

Conclusion

SchB， the main active component of SCF， may inhibit the expression of MMP9 in vascular smooth muscle by targeting STAT3 and other signal pathways， so as to reduce the degradation of extracellular matrix in aorta and inhibit the occurrence and development of TAA.

Key words: Network pharmacology, Schisandrae Chinensis Fructus, Thoracic aortic aneurysm, Molecular docking

CLC Number:

R543.1

Yan LI,Yue HOU,Xingwei MU,Bingqing LIU,Hong WAN,Chang LIU,Wei XIA. Network pharmacology and molecular docking analysis on mechanism of Schisandrae Chinensis Fructus in occurrence and development of thoracic aortic aneurysm[J].Journal of Jilin University(Medicine Edition), 2022, 48(2): 414-425.

Figures/Tables 14

Tab.1

Fig. 1

Fig. 2

Fig. 3

Fig. 4

Fig. 5

Fig. 6

Fig. 7

Fig. 9

Fig. 8

Fig. 10

Fig.11

Tab.2

Fig. 12

References 43

1	XIA L， SUN C， ZHU H， et al. Melatonin protects against thoracic aortic aneurysm and dissection through SIRT1-dependent regulation of oxidative stress and vascular smooth muscle cell loss［J］. J Pineal Res， 2020， 69（1）： e12661.
2	CHEN S Y， SHI J J， ZOU L S， et al. Quality evaluation of wild and cultivated Schisandrae Chinensis Fructus based on simultaneous determination of multiple bioactive constituents combined with multivariate statistical analysis［J］. Molecules， 2019， 24（7）：1335.
3	SHI P Y， GENG Q Q， CHEN L F， et al. Schisandra chinensis bee pollen's chemical profiles and protective effect against H2O2-induced apoptosis in H9c2 cardiomyocytes［J］. BMC Complementary Med Ther， 2020， 20（1）： 1-14.
4	JANG M A， LEE S J， BAEK S E， et al. A-iso-cubebene inhibits PDGF-induced vascular smooth muscle cell proliferation by suppressing osteopontin expression［J］. PLoS One， 2017， 12（1）： e0170699.
5	JEONG J W， KIM J W， KU S K， et al. Essential oils purified from Schisandrae semen inhibits tumor necrosis factor-α-induced matrix metalloproteinase-9 activation and migration of human aortic smooth muscle cells［J］. BMC Complement Altern Med， 2015， 15： 7.
6	WANG F， TU Y， GAO Y， et al. Smooth muscle sirtuin 1 blocks thoracic aortic aneurysm/dissection development in mice［J］. Cardiovas Drugs Ther， 2020， 34（5）： 641-650.
7	LI G， WANG M， CAULK A W， et al. Chronic mTOR activation induces a degradative smooth muscle cell phenotype［J］. J Clin Invest， 2020， 130（3）： 1233-1251.
8	GILLIS E， LVAN LAER， LOEYS B L. Genetics of thoracic aortic aneurysm： at the crossroad of transforming growth factor-β signaling and vascular smooth muscle cell contractility［J］. Circ Res， 2013， 113（3）： 327-340.
9	CHEN X L， XIAO Q L， PANG Z H， et al. Molecular mechanisms of An-Chuan Granule for the treatment of asthma based on a network pharmacology approach and experimental validation［J］. Biosci Rep， 2021， 41（3）： BSR20204247.
10	HUANG B， XIONG J， ZHAO X， et al. Network pharmacology-based analysis of the pharmacological mechanisms of aloperine on cardiovascular disease［J］. Evid Based Complement Alternat Med， 2020， 2020： 5180716.
11	HUANG B， HUANG C， ZHU L， et al. Exploring the pharmacological mechanisms of tripterygium wilfordii hook F against cardiovascular disease using network pharmacology and molecular docking［J］. Biomed Res Int， 2021， 2021： 5575621.
12	LI L， YANG D， LI J， et al. Investigation of cardiovascular protective effect of Shenmai injection by network pharmacology and pharmacological evaluation［J］. BMC Complement Med Ther， 2020， 20（1）： 112.
13	KIRÇA M， YEŞILKAYA A. Losartan inhibits EGFR transactivation in vascular smooth muscle cells［J］. Turkish J Med Sci， 2018， 48（6）： 1364-1371.
14	MUGABE B E， YAGHINI F A， SONG C Y， et al. Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation［J］. J Pharmacol Exp Ther， 2010， 332（1）： 116-124.
15	SHEN Y H， ZHANG L， GAN Y， et al. Up-regulation of PTEN （phosphatase and tensin homolog deleted on chromosome ten） mediates p38 MAPK stress signal-induced inhibition of insulin signaling. A cross-talk between stress signaling and insulin signaling in resistin-treated human endothelial cells［J］. J Biol Chem， 2006， 281（12）： 7727-7736.
16	LUO Z， FUJIO Y， KUREISHI Y， et al. Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo ［J］. J Clin Invest， 2000， 106（4）： 493-499.
17	LIU R， LO L， LAY A J， et al. ARHGAP18 protects against thoracic aortic aneurysm formation by mitigating the synthetic and proinflammatory smooth muscle cell phenotype［J］. Circ Res， 2017， 121（5）： 512-524.
18	BAI Z， GU J， SHI Y， et al. Effect of inflammation on the biomechanical strength of involved aorta in type A aortic dissection and ascending thoracic aortic aneurysm： An initial research［J］. Anatol J Cardiol， 2018， 20（2）： 85-92.
19	ISOLA G， POLIZZI A， RONSIVALLE V， et al. Impact of matrix metalloproteinase-9 during periodontitis and cardiovascular diseases［J］.Molecules，2021，26（6）： 1777.
20	YABLUCHANSKIY A， MA Y， IYER R P， et al. Matrix metalloproteinase-9： Many shades of function in cardiovascular disease［J］.Physiology （Bethesda）， 2013， 28（6）： 391-403.
21	WANG L， ASTONE M， ALAM S K， et al. Suppressing STAT3 activity protects the endothelial barrier from VEGF-mediated vascular permeability［J］. bioRxiv， Mol，Biol， 2020， 28（20）.DOI：10.1242/dmm.049029 . doi: 10.1242/dmm.049029
22	HU X， MA R， CAO J，et al.PTPN₂ negatively regulates macrophage inflammation in atherosclerosis［J］. Aging（Albany NY）， 2020， 13（2）： 2768-2779.
23	TANG H X， QIN X P， LI J. Role of the signal transducer and activator of transcription 3 protein in the proliferation of vascular smooth muscle cells［J］. Vascular， 2020， 28（6）： 821-828.
24	CHUN J N， PARK S， LEE S， et al. Schisandrol B and schisandrin B inhibit TGFβ1-mediated NF-κB activation via a Smad-independent mechanism［J］. Oncotarget， 2018， 9（3）： 3121-3130.
25	PICCOLO S R， SUN Y， CAMPBELL J D， et al. A single-sample microarray normalization method to facilitate personalized-medicine workflows［J］. Genomics， 2012， 100（6）： 337-344.
26	章晓云，李华南，陈锋，等. 网络药理学结合分子对接技术揭示桂枝芍药知母汤治疗痛风性关节炎的潜在分子机制［J］. 中国组织工程研究， 2022， 26（2）： 245-252.
27	LINDSAY M E， DIETZ H C. Lessons on the pathogenesis of aneurysm from heritable conditions［J］. Nature， 2011， 473（7347）： 308-316.
28	SHI X， GUO L W， SEEDIAL S M， et al. TGF-β/Smad3 inhibit vascular smooth muscle cell apoptosis through an autocrine signaling mechanism involving VEGF-A［J］. Cell Death Dis， 2014， 5（7）： e1317.
29	LIAO X H， XIANG Y， LI H， et al. VEGF-A stimulates STAT3 activity via nitrosylation of myocardin to regulate the expression of vascular smooth muscle cell differentiation markers［J］. Sci Rep， 2017， 7（1）： 2660.
30	LIAO X H， WANG N， ZHAO D W， et al. STAT3 protein regulates vascular smooth muscle cell phenotypic switch by interaction with myocardin［J］. J Biol Chem， 2015， 290（32）： 19641-19652.
31	WANG L， WU H， XIONG L， et al. Quercetin downregulates cyclooxygenase-2 expression and HIF-1α/VEGF signaling-related angiogenesis in a mouse model of abdominal aortic aneurysm［J］. Biomed Res Int， 2020， 2020： 9485398.
32	GEISSLER A， RYZHOV S， SAWYER D B. Neuregulins： protective and reparative growth factors in multiple forms of cardiovascular disease［J］. Clin Sci （Lond）， 2020， 134（19）： 2623-2643.
33	SUN Y， ZHANG S， YUE M， et al. Angiotensin Ⅱ inhibits apoptosis of mouse aortic smooth muscle cells through regulating the circNRG-1/miR-193b-5p/NRG-1 axis［J］. Cell Death Dis， 2019， 10（5）： 362.
34	MCCAFFREY T A. TGF-beta signaling in atherosclerosis and restenosis［J］. Front Biosci （Schol Ed）， 2009， 1： 236-245.
35	RUIZ-ORTEGA M， RODRíGUEZ-VITA J， SANCHEZ-LOPEZ E， et al. TGF-beta signaling in vascular fibrosis［J］. Cardiovasc Res， 2007， 74（2）： 196-206.
36	GOMEZ D， OWENS G K. Smooth muscle cell phenotypic switching in atherosclerosis［J］. Cardiovasc Res， 2012， 95（2）： 156-164.
37	FISHER S A. Vascular smooth muscle phenotypic diversity and function［J］. Physiol Genomics， 2010， 42A（3）： 169-187.
38	CHUN J N， KIM S Y， PARK E J， et al. Schisandrin B suppresses TGFβ1-induced stress fiber formation by inhibiting myosin light chain phosphorylation［J］. J Ethnopharmacol， 2014， 152（2）： 364-371.
39	PARK E J， CHUN J N， KIM S H， et al. Schisandrin B suppresses TGFβ1 signaling by inhibiting Smad2/3 and MAPK pathways［J］.Biochem Pharmacol，2012，83（3）： 378-384.
40	BEN P， HU M， WU H， et al. L-theanine down-regulates the JAK/STAT3 pathway to attenuate the proliferation and migration of vascular smooth muscle cells induced by angiotensin Ⅱ［J］. Biol Pharm Bull， 2018， 41（11）： 1678-1684.
41	DANIEL J M， DUTZMANN J， BIELENBERG W， et al. Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formation［J］. Basic Res Cardiol， 2012， 107（3）： 261.
42	LIU C， ZHANG C C， JIA L X， et al. Interleukin-3 stimulates matrix metalloproteinase 12 production from macrophages promoting thoracic aortic aneurysm/dissection［J］. Clin Sci， 2018， 132（6）： 655-668.
43	SCHMITT R， TSCHEUSCHLER A， LASCHINSKI P，et al. A potential key mechanism in ascending aortic aneurysm development： Detection of a linear relationship between MMP-14/TIMP-2 ratio and active MMP-2［J］. PLoS One， 2019， 14（2）： e0212859.

[1]	Shuang HAN,Jingwen HUANG,Yue SHI,Xinyue HUANG,Mengru GUO,Yi ZHENG,Ning MA. Network pharmacology analysis of mechanism of Taohong Siwu Decoction in treating periodontitis and its in vitro experimental validation [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 703-718.
[2]	Meng CAI,Yang GUO,Yingfang MA,Jinglei CUI,Jia LUO,Lili WEI,Yunhua ZHANG,Yang WANG. Therapeutic effect of prunetin on myocardial infarction model mice and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 125-134.
[3]	Huaimin LIANG,Jiacheng JIN,Wenhua CHEN,Yuyao LI,Hangyu WANG,Ke ZHANG,Jinhui WANG. UPLC-Q-TOF/MS and network pharmacology analysis and experimental verification based on potential active ingredients and mechanisms of medicinal Mulberry Leaves in anti-acute kidney injury [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 56-69.
[4]	Qiuyue WANG,Zhengning YANG,Xiaofeng HUANG,Minghan HUANG,Wenrong WANG. Network pharmacology and molecular docking analysis based on mechanism of Compound Gastritis Mixture in treatment of chronic atrophic gastritis [J]. Journal of Jilin University(Medicine Edition), 2025, 51(3): 691-702.
[5]	Xinchen ZHOU,Shuhan DONG,Zhuo ZHANG,Mingmei SHEN,Xiangjun WANG,Ying LI,Limei LIU. Network pharmacology analysis based on potential mechanism of dandelion-mulberry leaf in treatment of acute myeloid leukemia [J]. Journal of Jilin University(Medicine Edition), 2024, 50(4): 1087-1097.
[6]	Shan CAO,Yijia ZHANG,Yang BAI,Fang CHEN,Sha XIE,Qianqian HAN. Network pharmacological analysis and in vitro experimental verification based on anti-atherosclerosis mechanism of Xiaoban Tongmai Formula [J]. Journal of Jilin University(Medicine Edition), 2024, 50(4): 925-938.
[7]	Jinli TAN,Dan HUANG,Jingyang LIAO,Liuchong ZHU,Wenbin LIU. Molecular docking analysis on screening of novel antibacterial targets and their drugs of Staphylococcus aureus based on pan-genomics and subtractive proteomics techniques [J]. Journal of Jilin University(Medicine Edition), 2024, 50(4): 970-977.
[8]	Zijia ZHU,Xia CHEN,Man CUI,Jihong WEN,Ping WANG,Dong SONG. Bioinformatics and molecular docking technology analysis on mechanism of salidroside on key differential genes of triple negative breast cancer [J]. Journal of Jilin University(Medicine Edition), 2024, 50(3): 759-769.
[9]	Yang YU,Dan TIAN,Donghe NI,Duo ZHANG. Network pharmacologry and molecular docking analysis based on mechanism of monk fruit in treatment of diabetic nephropathy [J]. Journal of Jilin University(Medicine Edition), 2024, 50(1): 161-167.
[10]	Aiying CHEN,Jinwen JIANG,Hui ZHANG. Network pharmacology and molecular docking analysis based on mechanism of Huangqin Tang in treatment of colorectal cancer [J]. Journal of Jilin University(Medicine Edition), 2024, 50(1): 208-220.
[11]	Li LIU,Linsheng HUANG,Yongheng ZHAO,Wenjie CAO,Yongshuai QIAN,Huifan YU,Fei LI. Network pharmacological analysis on Balanophora involucrataHook.f. in treatment of hyperuricemia and its therapeutic effect on hyperuricemia cell model and hyperuricemia model mouse [J]. Journal of Jilin University(Medicine Edition), 2024, 50(1): 58-70.
[12]	Chunling WANG,Sinuo WU,Xiaoyan YU,Weidong ZHANG. Analysis on network pharmacology and molecular docking technique based on effective chemical components and action targets of epimedium in treatment of hypothalamus-pituitary- adrenal gland/ gonad / thyroid gland axis function damage [J]. Journal of Jilin University(Medicine Edition), 2023, 49(5): 1296-1303.
[13]	Sihan LAI,Juntong LIU,Luying TAN,Jinping LIU,Pingya LI. Network pharmacology and molecular docking analysis on anti-ischemic stroke mechanism of Panax quinquefolium triolsaponins [J]. Journal of Jilin University(Medicine Edition), 2023, 49(4): 913-922.
[14]	Yumeng LIU,Song LENG, SARENGAOWA,Daijie LIN,Linsheng XIE,Mengrui LI,Xiao XU,Wannan LI. Network pharmacology analysis based on therapeutic effect of Sanghuang on pneumonia and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2023, 49(4): 923-930.
[15]	Yushuang GONG,Yefan FU,Huijing XU,Jian GUO,Lin XIANG,Rui HU,Rui FAN,Jie WANG,Miao LI,Meiyan SUN. Network pharmacology analysis on mechanism of Tonifying Slpeen and Kidney Empirical Prescription in treatment of neuromyelitis optica spectrum disorders [J]. Journal of Jilin University(Medicine Edition), 2023, 49(2): 261-271.

Network pharmacology and molecular docking analysis on mechanism of Schisandrae Chinensis Fructus in occurrence and development of thoracic aortic aneurysm

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 14

References 43

Related Articles 15

Metrics

Comments

Recommended 10